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Abstract 
Background: The incidence of oropharyngeal cancer (OPC) has been rising, especially among 
middle-aged men. While Human Papillomavirus (HPV) has been irrevocably implicated in the 
pathogenesis of OPC, the current HPV immunization uptake rate remains low in the US. The aim 
of our study was to evaluate the impact of increased HPV vaccination coverage on HPV-
associated OPC incidence and costs. 
 
Methods: A decision analytic Markov model was constructed. Separate analyses were conducted 
for hypothetical cohorts of 9-year-old boys and girls. Two strategies were compared: 1) Status 
quo (maintaining the current vaccination uptake rates); 2) Increasing HPV vaccination uptake 
rates to the Healthy People 2020 target (80%) for both genders. Sensitivity analyses were 
performed to determine the impact of model input uncertainties on results. 
 
Results: Increasing HPV vaccination uptake rates to the Healthy People 2020 target would be 
expected to prevent nearly 100,000 cases of OPC and save $544 million by saving more than 
twice the amount for each dollar spent on vaccination over lifetime. Increased HPV vaccination 
coverage would result in 8,290 QALY gains in the overall population, and it would be cost-
saving for males and cost-effective for females with an incremental cost-effectiveness ratio of 
$42,365 per QALY gained for females. 
 
Conclusion: Expanding HPV vaccination rates would likely provide a cost-effective way to 
reduce the incidence of OPC in the US, particularly among males given their higher baseline risk 
of OPC and lower vaccination levels compared to females. Furthermore, widespread vaccination 
coverage would provide health benefits for other HPV-associated diseases. 
	
